Diagnostic News and Research

RSS

The Native Antigen Company wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards

The Native Antigen Company, part of LGC Clinical Diagnostics, won ‘The Best COVID-19 Responder’ at OBN 2020 Awards.

From The Native Antigen Company 14 Jun 2021

British Liver Trust calls for action to address rising obesity rates that fuel liver disease crisis

The British Liver Trust is calling for greater awareness of a silent yet serious form of fatty liver disease, non-alcohol related steatohepatitis (NASH), as one million adults were reported to have been admitted to hospital with obesity-related conditions in 2020.

14 Jun 2021

Novel computer system can help inform future therapies for patients with inherited heart disease

An integrated, genomic computer system for precision cardiology has been created using clinical data that can help inform medical and surgical decisions to support future therapies for patients with inherited heart disease.

14 Jun 2021

PET radiotracer can noninvasively identify and monitor pulmonary fibrosis

Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.

13 Jun 2021

AMP’s new consensus can promote standardization of PGx gene/allele testing, improve patient care

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP2D6 assays, promote standardization of testing across different laboratories and improve patient care

11 Jun 2021

Largest U.S. study shares first results on effects of COVID-19 on cancer patients

In the largest study of its kind to date, researchers analyzing national data from more than 63,000 patients with cancer and a positive COVID-19 diagnosis report an increased risk of death among those who were older, male, had a higher number of comorbidities, and had hematologic cancers and recent chemotherapy treatments.

11 Jun 2021

Innovative protocol that processes saliva samples before testing may improve COVID-19 detection

The collection of nasopharyngeal swab (NPS) samples for COVID-19 diagnostic testing poses challenges including exposure risk to healthcare workers and supply chain constraints. Saliva samples are easier to collect but can be mixed with mucus or blood, and some studies have found they produce less accurate results.

10 Jun 2021

LIM domain only 1 gene contributes to the tumorigenesis of multiple cancers

Humans have been plagued by a myriad of deadly cancers since ages. Parallelly, they have also been attempting different permutations and combinations of treatments to cure the disease. Part of these attempts involving biomolecular targets have come to the fore in recent years.

10 Jun 2021

Aptamer Group Ltd appoints Jordan Clark as Chief Commercial Officer

Aptamer Group, the developer of Optimer biotherapeutics and diagnostics, is pleased to announce the appointment of Jordan Clark as Chief Commercial Officer at Aptamer Group with immediate effect.

From Aptamer Group 10 Jun 2021

Deep neural network model can accurately predict the brain age of healthy patients

A study shows that a deep neural network model can accurately predict the brain age of healthy patients based on electroencephalogram data recorded during an overnight sleep study, and EEG-predicted brain age indices display unique characteristics within populations with different diseases.

10 Jun 2021

Trained dogs can accurately identify COVID-19 by scent

An interesting new medRxiv* preprint reveals that with careful training, the exquisite scent sensitivity of dogs may be exploited to rule out the presence of coronavirus disease 2019 (COVID-19) in human beings in real-time.

9 Jun 2021

Review of COVID-19's long-term effects

In a recent study, Canadian researchers documented the prevalence of post-COVID-19 conditions 4-12 weeks (short-term) and >12 weeks (long-term), by conducting a systematic review of peer-reviewed literature. This work is posted to the medRxiv* preprint server.

9 Jun 2021

European grant awarded for innovative orthopedic training simulator

June 9, 2021, Zurich, Switzerland: VirtaMed, the world leader in data-driven medical simulation training, together with the Centre Hospitalier de Luxembourg (CHL), a public hospital of Luxembourg city, will develop a mixed reality simulator to support surgical skills training for advanced arthroscopic meniscus repair.

From VirtaMed 9 Jun 2021

Radiometer launches the next generation of transcutaneous monitoring in Canada

Radiometer has unveiled its Health Canada licensed TCM5 transcutaneous monitor, addressing the critical care needs of neonatal, pediatric, and adult patients, as well as sleep clinic

From Radiometer Medical 9 Jun 2021

KA Imaging signs Australian distributor - Regional Health Care Group

Medical distribution company Regional Health Care Group will now be bringing KA Imaging’s innovative X-ray technologies to Australia and New Zealand.

From KA Imaging 9 Jun 2021

AI-powered tool could accelerate the diagnosis of cardiovascular diseases

A team of researchers from Nanyang Technological University, Singapore, Ngee Ann Polytechnic, Singapore, and the National Heart Centre Singapore have invented a tool that could speed up the diagnosis of cardiovascular diseases.

8 Jun 2021

MIT researchers develop a molecular assay to detect sub-picomolar levels of the SARS-CoV-2's receptor-binding domain

A team of researchers at MIT has developed a molecular assay to detect sub-picomolar levels of the SARS-CoV-2’s spike protein receptor-binding domain (S-RBD) using computationally validated peptide beacons in a single-step detection through the production of a fluorescence signal.

8 Jun 2021

Mass vaccination the only way to tackle emerging SARS-CoV-2 variants

Researchers from Poland recently analyzed key information concerning SARS-CoV-2 variants, such as their infectivity, mutations, severity, and immune susceptibility. Their work is published in the open-access journal Pathogens.

8 Jun 2021

Immunomodulatory therapies for nephrological autoimmune diseases may help treat severe COVID-19

Various viruses and bacteria have long been known to cause autoimmune diseases where there is such a predisposition. This phenomenon also seems to play a major role in SARS-CoV-2, especially in severe courses.

8 Jun 2021

FDA approves monoclonal antibody aducanumab for treating Alzheimer's patients

Today's FDA approval of the monoclonal antibody Aduhelm (aducanumab) to treat patients with Alzheimer's disease reflects years of significant advances in Alzheimer's research. This is the first new Alzheimer's drug approved in 17 years and the first shown to modify the course of the disease, which FDA believes will lead to slowing of patients' cognitive decline.

8 Jun 2021

Diagnostic News and Research

The Native Antigen Company wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards

British Liver Trust calls for action to address rising obesity rates that fuel liver disease crisis

Novel computer system can help inform future therapies for patients with inherited heart disease

PET radiotracer can noninvasively identify and monitor pulmonary fibrosis

AMP’s new consensus can promote standardization of PGx gene/allele testing, improve patient care

Largest U.S. study shares first results on effects of COVID-19 on cancer patients

Innovative protocol that processes saliva samples before testing may improve COVID-19 detection

LIM domain only 1 gene contributes to the tumorigenesis of multiple cancers

Aptamer Group Ltd appoints Jordan Clark as Chief Commercial Officer

Deep neural network model can accurately predict the brain age of healthy patients

Trained dogs can accurately identify COVID-19 by scent

Review of COVID-19's long-term effects

European grant awarded for innovative orthopedic training simulator

Radiometer launches the next generation of transcutaneous monitoring in Canada

KA Imaging signs Australian distributor - Regional Health Care Group

AI-powered tool could accelerate the diagnosis of cardiovascular diseases

MIT researchers develop a molecular assay to detect sub-picomolar levels of the SARS-CoV-2's receptor-binding domain

Mass vaccination the only way to tackle emerging SARS-CoV-2 variants

Immunomodulatory therapies for nephrological autoimmune diseases may help treat severe COVID-19

FDA approves monoclonal antibody aducanumab for treating Alzheimer's patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News